Cystic fibrosis-related diabetes testing in Nogarole Vicentino
Find health labs to test for Cystic fibrosis-related diabetes in Nogarole Vicentino and compare all offers by prices and services.
test prediabete e diabete con autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€35.00
€33.25 with our promocode
See Details
Diabetes Test by Synlab
Via Sorte, 48, 37047 San Bonifacio VR, Italia
11.3 km
Hemoglobin Test by Synlab Euganea Medica
Via Cristoforo Colombo, 13, 35020 Albignasego PD, Italia
31.8 km
Hemoglobin Test by Synlab
Via Antonio Zanchi, 89, 35133 Padova PD, Italia
30.4 km
Hemoglobin Test by Synlab
Via Giovanni Boccaccio, 106, 35128 Padova PD, Italia
30.4 km
Hemoglobin Test by Casa della Salute
Via Cesare Battisti, 99, 38042 Baselga di Pinè TN, Italia
39.5 km
Diabetes Test by GmLab sede di Locorotondo (BA)
Viale Giosuè Carducci, 3, 44034 Copparo FE, Italia
52.9 km
Diabetes Test by Synlab
Campo Guglielmo Marconi, 24, 30015 Chioggia VE, Italia
53.5 km
Hemoglobin Test by Farmacia Beata Vergine della Salute
Corso Canalchiaro, 127, 41121 Modena MO, Italia
65.5 km
Diabetes Test by Laboratorio Analisi Cliniche Girlando e Paravizzini
Viale Giuseppe Di Vittorio, 10, 45018 Porto Tolle RO, Italia
66 km
Unverified
A Diabetes Test costs €50.00
See Details
Hemoglobin Test by Farmacia Manganelli
Via degli Alpini, 2, 24064 Grumello del Monte BG, Italia
68.8 km
Cystic fibrosis-related diabetes - symptoms and how to test
Diabetes mellitus is a common disease; however, cystic fibrosis can cause a unique type of disease called cystic fibrosis-related diabetes (CFRD). This type of diabetes mellitus is different from both type 1, and type 2 diabetes yet has specific characteristics. The primary reason is insulin insufficiency due to islet cell death. Adults and adolescents with cystic fibrosis often develop diabetes because of their condition. Moreover, a third of CF patients aged 16 and up are receiving therapy for CFRD, according to 2018 data from the UK CF Registry. Among children aged 10 to 15, just 11% are receiving medication. There is evidence that early treatment of diabetes improves prognosis, and the fact that diabetes and poor glucose tolerance are both associated with worse health outcomes in people with CF emphasises the necessity of an early diagnosis.
